{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:53:27Z","timestamp":1785336807282,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ncl.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T10:48:55Z","timestamp":1637146135000},"page":"33-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inpatient Management of Acute Stroke and Transient Ischemic Attack"],"prefix":"10.1016","volume":"40","author":[{"given":"Lauren","family":"Patrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathra","family":"Halabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ncl.2021.08.003_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1941875210392052","article-title":"Quality measures in stroke","volume":"1","author":"Poisson","year":"2011","journal-title":"Neurohospitalist"},{"issue":"11","key":"10.1016\/j.ncl.2021.08.003_bib3","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1161\/STR.0000000000000045","article-title":"Clinical performance measures for adults hospitalized with acute ischemic stroke: performance measures for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Smith","year":"2014","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.ncl.2021.08.003_bib4","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.ncl.2021.08.003_bib5","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"Easton","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.003_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.08.003_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2017.05.019","article-title":"Etiologic classification of ischemic stroke: where do we stand?","volume":"159","author":"Radu","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.003_bib8","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.003_bib9","first-page":"530","article-title":"ABCD3-I score and the risk of early or 3-month stroke recurrence in tissue- and time-based definitions of TIA and minor stroke","volume":"265","author":"Mayer","year":"2018","journal-title":"J\u00a0Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2021.08.003_bib10","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1161\/STROKEAHA.113.000878","article-title":"Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: part 1: rapidly improving stroke symptoms","volume":"44","author":"Levine","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.003_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ncl.2021.08.003_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.119.040713","article-title":"Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke","volume":"140","author":"Johnston","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ncl.2021.08.003_bib13","first-page":"1","article-title":"Ticagrelor added to aspirin in acute ischemic stroke or transient ischemic attack in prevention of disabling stroke: a randomized clinical trial","volume":"78","author":"Amarenco","year":"2020","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.003_bib14","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.003_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12028-010-9404-8","article-title":"Treating hyperglycemia in neurocritical patients: benefits and perils","volume":"13","author":"Godoy","year":"2010","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.003_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jama.2019.9346","article-title":"Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial","volume":"322","author":"Johnston","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ncl.2021.08.003_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1474-4422(09)70051-1","article-title":"The Paracetamol (Acetaminophen) in stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial","volume":"8","author":"den Hertog","year":"2009","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.003_bib18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.STR.0000116869.64771.5A","article-title":"Blood pressure and stroke: an overview of published reviews","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.003_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1910355","article-title":"A\u00a0comparison of two LDL cholesterol targets after ischemic stroke","volume":"382","author":"Amarenco","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ncl.2021.08.003_bib20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/STROKEAHA.106.475525","article-title":"Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study","volume":"38","author":"Hackam","year":"2007","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.003_bib21","first-page":"E76","volume":"81","author":"Brott","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.ncl.2021.08.003_bib22","article-title":"Immediate versus delayed treatment for recently symptomatic carotid artery stenosis","volume":"9","author":"Vasconcelos","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.003_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1474-4422(19)30149-8","article-title":"Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis","volume":"18","author":"Markus","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9352","key":"10.1016\/j.ncl.2021.08.003_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0140-6736(03)12228-3","article-title":"Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis","volume":"361","author":"Rothwell","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ncl.2021.08.003_bib25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/STROKEAHA.116.016233","article-title":"Early endarterectomy carries a lower procedural risk than early stenting in patients with symptomatic stenosis of the internal carotid artery: results from 4 randomized controlled trials","volume":"48","author":"Rantner","year":"2017","journal-title":"Stroke"},{"issue":"9967","key":"10.1016\/j.ncl.2021.08.003_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(14)61184-3","article-title":"Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial","volume":"385","author":"Bonati","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.003_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0912321","article-title":"Stenting versus endarterectomy for treatment of carotid-artery stenosis","volume":"363","author":"Brott","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ncl.2021.08.003_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(08)70195-9","article-title":"Endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial","volume":"7","author":"Mas","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.003_bib29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/STROKEAHA.110.610212","article-title":"Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)","volume":"42","author":"Silver","year":"2011","journal-title":"Stroke"},{"issue":"15","key":"10.1016\/j.ncl.2021.08.003_bib30","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa040127","article-title":"Protected carotid-artery stenting versus endarterectomy in high-risk patients","volume":"351","author":"Yadav","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ncl.2021.08.003_bib31","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jama.2017.12882","article-title":"Carotid endarterectomy and carotid artery stenting in the US medicare population, 1999-2014","volume":"318","author":"Lichtman","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2021.08.003_bib32","article-title":"TransCarotid Revascularization with dynamic flow reversal versus carotid endarterectomy in the vascular quality initiative surveillance project","author":"Malas","year":"2020","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.003_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jvs.2018.05.011","article-title":"Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative","volume":"69","author":"Malas","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"issue":"13","key":"10.1016\/j.ncl.2021.08.003_bib34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"Chimowitz","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ncl.2021.08.003_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.003_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(15)70018-9","article-title":"Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial","volume":"14","author":"Markus","year":"2015","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2021.08.003_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1474-4422(21)00044-2","article-title":"Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial","volume":"20","author":"Engelter","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.003_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1747-4949.2011.00725.x","article-title":"Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes","volume":"7","author":"Moran","year":"2012","journal-title":"Int J Stroke"},{"issue":"10","key":"10.1016\/j.ncl.2021.08.003_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamaneurol.2018.1073","article-title":"Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review","volume":"75","author":"Regenhardt","year":"2018","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.003_bib40","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.ncl.2021.08.003_bib41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jacc.2007.11.053","article-title":"Cardiogenic and aortogenic brain embolism","volume":"51","author":"Doufekias","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"26","key":"10.1016\/j.ncl.2021.08.003_bib42","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.ncl.2021.08.003_bib43","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ncl.2021.08.003_bib44","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1212\/WNL.0000000000003063","article-title":"The value of transesophageal echocardiography for embolic strokes of undetermined source","volume":"87","author":"Katsanos","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.003_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(18)30356-9","article-title":"Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation","volume":"18","author":"Seiffge","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9921","key":"10.1016\/j.ncl.2021.08.003_bib46","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.003_bib47","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2019.0591","article-title":"Tailoring the approach to embolic stroke of undetermined source: a review","volume":"76","author":"Kamel","year":"2019","journal-title":"JAMA Neurol"},{"issue":"19","key":"10.1016\/j.ncl.2021.08.003_bib48","doi-asserted-by":"crossref","first-page":"e012877","DOI":"10.1161\/JAHA.119.012877","article-title":"Inherited thrombophilia and the risk of arterial ischemic stroke: a systematic review and meta-analysis","volume":"8","author":"Chiasakul","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"21","key":"10.1016\/j.ncl.2021.08.003_bib49","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","article-title":"CLINICAL PRACTICE. Cryptogenic stroke","volume":"374","author":"Saver","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ncl.2021.08.003_bib50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","article-title":"Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study","volume":"14","author":"Li","year":"2015","journal-title":"Lancet Neurol"},{"issue":"20","key":"10.1016\/j.ncl.2021.08.003_bib51","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ncl.2021.08.003_bib52","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ncl.2021.08.003_bib53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M17-2679","article-title":"Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis","volume":"168","author":"Shah","year":"2018","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ncl.2021.08.003_bib54","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"issue":"35","key":"10.1016\/j.ncl.2021.08.003_bib55","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","article-title":"Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis","volume":"36","author":"Kent","year":"2015","journal-title":"Eur Heart J"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386192100075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386192100075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:19:10Z","timestamp":1760005150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386192100075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S073386192100075X"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2021.08.003","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inpatient Management of Acute Stroke and Transient Ischemic Attack","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}